Feb 7 (Reuters) - ESSA Pharma Inc EPIX.O :
* ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS
FINANCIAL
RESULTS FOR FISCAL FIRST QUARTER ENDED DECEMBER 31, 2022
* ESSA PHARMA INC- COMPANY'S CASH POSITION IS EXPECTED TO BE
SUFFICIENT TO FUND CURRENT AND PLANNED OPERATIONS THROUGH 2025
* ESSA PHARMA INC- AT DECEMBER 31, 2022, COMPANY HAD
AVAILABLE
CASH RESERVES AND SHORT-TERM INVESTMENTS OF $163.1 MILLION
* ESSA PHARMA INC - QTRLY LOSS PER SHARE $0.15
Source text for Eikon: ID:nPn3C8tGNa
Further company coverage: EPIX.O
((Reuters.Briefs@thomsonreuters.com;))